MedTrace Logo

Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers

NCT02259998 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-10-09

No results posted yet for this study

Summary

To investigate the relative bioavailability of the proposed formulation of PERSANTIN® compared to the present commercial formulation.

Conditions

  • Healthy

Interventions

DRUG

Persantin® new formulation

DRUG

Persantin® commercial formulation

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2001-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02259998 on ClinicalTrials.gov